EXPRESSION VECTOR PRODUCTION AND HIGH-THROUGHPUT CELL SCREENING

(19)

(11)

EP 3 047 022 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	19.08.2020 Bulletin 2020/34

(45)	Mention of the grant of the patent:
	08.07.2020 Bulletin 2020/28

(21)	Application number: 14772197.1

(22)	Date of filing: 18.09.2014

(51)

International Patent Classification (IPC):

C12N 15/09^(2006.01)

(86)	International application number:
	PCT/GB2014/052836

(87)	International publication number:
	WO 2015/040401 (26.03.2015 Gazette 2015/12)

(54)	EXPRESSION VECTOR PRODUCTION AND HIGH-THROUGHPUT CELL SCREENING EXPRESSIONSVEKTORPRODUKTION UND ZELLSCREENING MIT HOHEM DURCHSATZ PRODUCTION D'UN VECTEUR D'EXPRESSION ET CRIBLAGE CELLULAIRE À HAUT RENDEMENT

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

19.09.2013 GB 201316644

(43)	Date of publication of application:
	27.07.2016 Bulletin 2016/30

(60)	Divisional application:
	20184286.1

(73)	Proprietor: Kymab Limited
	Cambridge CB22 3AT (GB)

(72)	Inventors:
	BRADLEY, Allan Cambridge CB22 3AT (GB) LEE, E-Chiang Cambridge CB22 3AT (GB) LIANG, Qi Cambridge CB22 3AT (GB) LIU, Hui Cambridge CB22 3AT (GB) WOOD, Andrew Cambridge CB22 3AT (GB) WONG, Vivian Cambridge CB22 3AT (GB)

(74)	Representative: CMS Cameron McKenna Nabarro Olswang LLP
	Cannon Place 78 Cannon Street London EC4N 6AF London EC4N 6AF (GB)

(56)

References cited: :

WO-A1-2013/000982

DUVALL MARCUS ET AL: "A novel platform to produce human monoclonal antibodies The next generation of therapeutic human monoclonal antibodies discovery", MABS, vol. 3, no. 2, March 2011 (2011-03), pages 203-208, XP002735672,
DEKOSKY BRANDON J ET AL: "High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire", NATURE BIOTECHNOLOGY, vol. 31, no. 2, February 2013 (2013-02), pages 166-169, XP002735673,
KUROSAWA NOBUYUKI ET AL: "Rapid production of antigen-specific monoclonal antibodies from a variety of animals", BMC BIOLOGY, vol. 10, September 2012 (2012-09), XP002735674, ISSN: 1741-7007

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).